In 2010, Takakura et al. found that CDX2, a member of the caudal-related homeobox transcription factor gene family, can positively regulate the expression of MDR1 [14] and thus modulate the multi-drug resistance of tumor cells. The gene discussed is CDX2; the disease is neoplasm.